A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the

Jin Wen1, Yan Wen, Li Zhiliang

  • 1Cardiovascular Department, Zhujiang Hospital, Southern Medical University, Haizhu Area, Guangzhou, Guangdong, China.

Heart and Vessels
|January 10, 2012
PubMed

Insights

Reduced circulating myeloid dendritic cell (mDC) precursors correlate with coronary artery disease severity. This finding highlights mDC precursors as potential biomarkers for coronary heart disease progression and inflammation.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Atherosclerosis Research

Background:

  • Inflammation is central to coronary heart disease (CHD).
  • Dendritic cells (DCs), including myeloid DCs (mDCs) and plasmacytoid DCs (pDCs), are key immune cells involved in inflammation and atherosclerosis.
  • Circulating DC precursors in CHD are not fully understood, especially their relation to lesion severity.

Purpose of the Study:

  • To investigate the levels of circulating myeloid dendritic cell (mDC) and plasmacytoid dendritic cell (pDC) precursors in patients with varying degrees of coronary artery disease.
  • To assess the correlation between these DC precursors, coronary artery lesion severity (Gensini score), and inflammatory markers (MCP-1, MMP-9).

Main Methods:

  • Recruited controls and patients with stable angina pectoris (SAP), unstable angina pectoris (UAP), and acute myocardial infarction (AMI).
  • Quantified circulating mDC and pDC precursors using fluorescence-activated cell sorting (FACS).
  • Measured plasma levels of MCP-1 and MMP-9 and determined coronary artery lesion severity via Gensini score.

Main Results:

  • Percentage of circulating mDC precursors was significantly reduced in AMI and UAP patients compared to controls and SAP patients.
  • No significant change was observed in circulating pDC precursors.
  • Plasma levels of MMP-9, MCP-1, and Gensini scores were elevated in AMI and UAP patients.
  • Circulating mDC precursor percentage showed a negative correlation with MCP-1, MMP-9, and Gensini scores.

Conclusions:

  • Reduced circulating mDC precursors are associated with increased coronary artery lesion severity and inflammation in CHD patients.
  • mDC precursors may serve as a potential biomarker for CHD severity and progression.
  • Further research is warranted to explore the precise role of mDC precursors in atherogenesis.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...